跳至主要内容
临床试验/NCT03622320
NCT03622320已完成不适用

Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo

Cairo University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2018年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
1
主要终点
Central obesity as a Metabolic risk in vitiligo patients

研究概览

简要总结

This study aims at detection of possible associated metabolic syndrome with vitiligo and assessment of possible contribution of the age of onset of vitiligo.

详细描述

This study aims at detection of incidence of metabolic syndrome in vitiligo patients and possible contribution of the age of onset of the disease. This involves detection of waist circumference, body mass index, index of central obesity, systolic and diastolic arterial blood pressure, fasting blood sugar, high density lipoproteins and triglycerides, in addition to insulin resistance as Homeostatic Model Assessment- insulin resisitance (HOMA-IR) and serum leptin in vitiligo patients. The outcomes will be correlated to extent/ severity/duration/ activity of vitiligo as well as to the age of onset. This is assumed to be of profound impact on vitiligo patients by properly assessing these patients for associated metabolic risk factors and helping prevent such metabolic derangements by detection of possible contributing factors such as insulin resistance and high serum adipokines as leptin.

Since there is temporal relation between nutrition, metabolic derangements and skin diseases where nutritional deficiencies as minerals, vitamins and fatty acids can lead to cutaneous manifestations and , on the other hand; skin diseases could contribute to metabolic derangements and nutritional deficiencies, the investigator's study will focus on nutrition and dietary habits and there possible contribution to any associated metabolic risk in vitiligo patients.

This is likely to open new horizons in the management of vitiligo, possibly through control of metabolic syndrome risk factors and insulin resistance as well as revealing possible temporal relation to dietary habits that are overlooked in vitiligo patients.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Both genders
  • Patients with non-segmental vitiligo (NSV) and segmental vitiligo

排除标准

  • Pregnancy
  • Systemic steroid intake in the last 6 months

结局指标

主要结局

Central obesity as a Metabolic risk in vitiligo patients

时间窗: one year

Central obesity will be assessed using waist circumference in cm in vitiligo patients and control group as a risk factor for metabolic syndrome

次要结局

  • Arterial Blood Pressure as a Metabolic risk in vitiligo patients(one year)
  • Serum Triglycerides and HDL(one year)
  • Detection of insulin resistance in patients with vitiligo(one year)
  • Correlation between extent/ severity/duration/ activity of vitiligo and possible associated metabolic derangements.(one year)
  • Detection of possible influence of dietary habits and its relation to metabolic derangements and disease progression(one year)
  • Body mass index as a Metabolic risk in vitiligo patients(one year)
  • Fasting Blood pressure as a Metabolic risk in vitiligo patients(one year)
  • Correlation between extent/ severity/duration/ activity of vitiligo and the age of onset.(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rania Mogawer

Principal investigator

Cairo University

研究点 (1)

Loading locations...

相似试验